Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ARRXF | US
0.04
27.58%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
16/09/2024
0.20
0.20
0.20
0.20
Archer Materials Limited a technology company engages in development and commercialization of semiconductor devices and processor chips related to quantum computing and medical diagnostics in Australia. It primarily focuses on the development of qubit processor chip that operates at room temperature and integrate into modern electronics; and graphene-based lab-on-a-chip technology. The company was formerly known as Archer Exploration Limited and changed its name to Archer Materials Limited in October 2019. Archer Materials Limited was incorporated in 2007 and is based in Adelaide Australia.
View LessPositive Momentum
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
388.0%1 month
373.9%3 months
271.5%6 months
214.5%-
-
2.70
0.01
0.00
-3.14
-
-
-5.11M
50.30M
50.30M
-
-182.51
-
46.90
-20.10
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.08
Range1M
0.10
Range3M
0.15
Rel. volume
0.90
Price X volume
319.08
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals Inc | EGRX | Drug Manufacturers-Specialty & Generic | 4.23 | 54.81M | -1.86% | 5.07 | 27.85% |
DURECT Corporation | DRRX | Drug Manufacturers-Specialty & Generic | 1.56 | 48.42M | 3.31% | n/a | 318.92% |
Qilian International Holding Group Limited | QLI | Drug Manufacturers-Specialty & Generic | 7.115 | 42.47M | 9.80% | n/a | 1.35% |
Provectus Biopharmaceuticals Inc | PVCT | Drug Manufacturers-Specialty & Generic | 0.0897 | 37.67M | -7.53% | n/a | 0.00% |
BGXX | BGXX | Drug Manufacturers-Specialty & Generic | 0.1956 | 37.39M | -1.51% | n/a | 5.20% |
India Globalization Capital Inc | IGC | Drug Manufacturers-Specialty & Generic | 0.3515 | 26.59M | -1.35% | n/a | 4.33% |
Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 4.75 | 25.40M | 3.04% | n/a | 0.00% |
MEI Pharma Inc | MEIP | Drug Manufacturers-Specialty & Generic | 3.05 | 20.32M | 0.66% | 0.77 | 22.86% |
Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 1.25 | 17.62M | -3.10% | n/a | 81.86% |
Flora Growth Corp. Common Stock | FLGC | Drug Manufacturers-Specialty & Generic | 1.05 | 14.03M | 8.47% | n/a | 76.81% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 4.34 | 46.99M | 46.37% | n/a | 54.96% |
ILAG | ILAG | Building Products & Equipment | 1.11 | 20.05M | -5.12% | n/a | 5.48% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 12.43M | -4.67% | n/a | 16.03% |
The Dixie Group Inc | DXYN | Textile Manufacturing | 0.6979 | 10.73M | -6.40% | n/a | 422.08% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.6123 | 5.83M | 14.73% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2436 | 3.84M | -1.58% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.335 | 3.41M | 1.91% | n/a | 9.62% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.7963 | 1.17M | 2.13% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 915.21K | -17.29% | n/a | -37.05% |
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.18 | 0 | -0.21% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.14 | - | Cheaper |
Ent. to Revenue | - | - | - |
PE Ratio | - | 29.14 | - |
Price to Book | 2.70 | 12.81 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 271.48 | - | Riskier |
Debt to Equity | 0.01 | -0.93 | Expensive |
Debt to Assets | 0.00 | 0.45 | Cheaper |
Market Cap | 50.30M | - | Emerging |